- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Malaria and Sickle Cell Disease Treatment Market is expected to reach US$ 29,179.60 million by 2030
Nov 03, 2023
Novartis scraps sale of assets including COVID-19 hopeful to Indis's Aurobindo Pharma
Apr 02, 2020
Oral Anti-Diabetes Drugs Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2027
Apr 06, 2021
Synthetic Menthol Market Overview | COVID-19 Pandemic Impact, Competitive Landscape, Size, Value Demand, Regional Analysis and Forecast to 2027
May 06, 2021
NORTH AMERICA DRY EYE PRODUCT MARKET IS ANTICIPATED TO GROW WITH A CAGR OF 5.0% FROM 2019 TO 2027 , according to Business Market Insights
Jan 28, 2021
Rx Green Technologies Launches New Clean Coco Coir Products
May 05, 2020
Generic Oncology Drugs Market Size to Grow with Stupendous CAGR of 6.3% from Forecasts 2019 – 2027 | Zydus Cadila, Glenmark, Aurobindo Pharma
Feb 11, 2021